HSBC Holdings’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $219K | Sell |
12,085
-15,439
| -56% | -$280K | ﹤0.01% | 2167 |
|
|
2025
Q1 | $531K | Sell |
27,524
-2,212
| -7% | -$42.6K | ﹤0.01% | 1627 |
|
|
2024
Q4 | $511K | Buy |
29,736
+8,186
| +38% | +$141K | ﹤0.01% | 1774 |
|
|
2024
Q3 | $426K | Sell |
21,550
-23,778
| -52% | -$470K | ﹤0.01% | 1745 |
|
|
2024
Q2 | $500K | Sell |
45,328
-7,298
| -14% | -$80.5K | ﹤0.01% | 1630 |
|
|
2024
Q1 | $347K | Buy |
52,626
+19,157
| +57% | +$126K | ﹤0.01% | 1932 |
|
|
2023
Q4 | $153K | Buy |
33,469
+7,360
| +28% | +$33.7K | ﹤0.01% | 2060 |
|
|
2023
Q3 | $94.3K | Buy |
+26,109
| New | +$94.3K | ﹤0.01% | 2058 |
|
|
2023
Q1 | – | Sell |
-14,034
| Closed | -$54.5K | – | 2198 |
|
|
2022
Q4 | $54.5K | Buy |
+14,034
| New | +$54.5K | ﹤0.01% | 2470 |
|
|
2022
Q2 | – | Sell |
-31,968
| Closed | -$59K | – | 2769 |
|
|
2022
Q1 | $59K | Hold |
31,968
| – | – | ﹤0.01% | 2799 |
|
|
2021
Q4 | $45K | Sell |
31,968
-15
| -0% | -$21 | ﹤0.01% | 2712 |
|
|
2021
Q3 | $36K | Sell |
31,983
-1,225
| -4% | -$1.38K | ﹤0.01% | 2464 |
|
|
2021
Q2 | $53K | Buy |
33,208
+15
| +0% | +$24 | ﹤0.01% | 2440 |
|
|
2021
Q1 | $59K | Buy |
+33,193
| New | +$59K | ﹤0.01% | 2275 |
|